Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Trent

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Gastrointestinal Cancer Research : GCR|March 5, 2009
Toward personalized, targeted therapy of gastrointestinal stromal tumorJonathan C Trent
Current Opinion in Oncology|June 6, 2008
Rapid evolution of the biology and treatment of sarcomaJonathan C Trent
Cancer Chemotherapy and Pharmacology|December 9, 2010
The role of imatinib plasma level testing in gastrointestinal stromal tumorSuzanne George, Jonathan C Trent
Current Opinion in Oncology|June 4, 2010
Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developmentsDavid Reynoso, Jonathan C Trent
Hematology/Oncology Clinics of North America|March 3, 2009
Clinical update on adult and pediatric gastrointestinal stromal tumor. PrefaceJonathan C Trent, Shreyaskumar R Patel
International Journal of Cancer|June 15, 2011
Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumorsBurton L Eisenberg, Jonathan C Trent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Biomarkers in gastrointestinal stromal tumor: should we equate blood-based pharmacodynamics with tumor biology and clinical outcomes?John C McAuliffe, Jonathan C Trent
Current Opinion in Oncology|May 25, 2006
New developments in gastrointestinal stromal tumorJonathan C Trent, Robert S Benjamin
Expert Review of Anticancer Therapy|October 24, 2014
Managing GIST in the imatinib era: optimization of adjuvant therapyJonathan C Trent, Meenakshi P Subramanian
Chinese Journal of Cancer|April 30, 2011
Gastrointestinal stromal tumor and its targeted therapeuticsJheri Dupart, Wei Zhang, Jonathan C Trent
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Gastrointestinal Cancer Research : GCR|March 5, 2009
Toward personalized, targeted therapy of gastrointestinal stromal tumorJonathan C Trent
Current Opinion in Oncology|June 6, 2008
Rapid evolution of the biology and treatment of sarcomaJonathan C Trent
Cancer Chemotherapy and Pharmacology|December 9, 2010
The role of imatinib plasma level testing in gastrointestinal stromal tumorSuzanne George, Jonathan C Trent
Current Opinion in Oncology|June 4, 2010
Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developmentsDavid Reynoso, Jonathan C Trent
Hematology/Oncology Clinics of North America|March 3, 2009
Clinical update on adult and pediatric gastrointestinal stromal tumor. PrefaceJonathan C Trent, Shreyaskumar R Patel
International Journal of Cancer|June 15, 2011
Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumorsBurton L Eisenberg, Jonathan C Trent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Biomarkers in gastrointestinal stromal tumor: should we equate blood-based pharmacodynamics with tumor biology and clinical outcomes?John C McAuliffe, Jonathan C Trent
Current Opinion in Oncology|May 25, 2006
New developments in gastrointestinal stromal tumorJonathan C Trent, Robert S Benjamin
Expert Review of Anticancer Therapy|October 24, 2014
Managing GIST in the imatinib era: optimization of adjuvant therapyJonathan C Trent, Meenakshi P Subramanian
Chinese Journal of Cancer|April 30, 2011
Gastrointestinal stromal tumor and its targeted therapeuticsJheri Dupart, Wei Zhang, Jonathan C Trent
Pageof 14